-
Mashup Score: 44The Promise of Liquid Biopsies | Cancer Today - 17 day(s) ago
Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
Source: www.cancertodaymag.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 52Circulating tumour cell enumeration, biomarker analyses, and kinetics in patients with colorectal cancer and other GI malignancies - 5 month(s) ago
ObjectiveMost of the work in terms of liquid biopsies in patients with solid tumors is focused on circulating tumor DNA (ctDNA). Our aim was to evaluate the feasibility of using circulating tumor cells (CTCs) in peripheral blood samples from patients with advanced or metastatic gastrointestinal (GI) cancers.MethodsIn this prospective study, blood samples were collected from each patient in 2 AccuCyte® blood collection tubes and each tube underwent CTC analysis performed utilizing the RareCyte® platform. The results from both tubes were averaged and a total of 150 draws were done, with 281 unique reported results. The cadence of sampling was based on convenience sampling and piggybacked onto days of actual clinical follow-ups and treatment visits. The CTC results were correlated with patient- and tumor-related variables.ResultsData from a total of 59 unique patients were included in this study. Patients had a median age of 58 years, with males representing 69% of the study population. M
Source: www.frontiersin.orgCategories: General Medicine News, Hem/OncsTweet-
Our 1st work on Circulating Tumor Cells➖CTCs🟣🔵🟠as #LiquidBiopsies. Published @FrontOncology. Using @RareCyte ✅Feasible ⬇️Cost ➡️Tons in colorectal🆚pancreas ✔️HER2 ✔️PDL1 📉Kinetics 🙌🏾Teamwork @MlkwWalaa @AliasgerSalem @OncoAlert @isliquidbiopsy https://t.co/4ogX3ykDiu https://t.co/Zf6sqwMV5d
-
-
Mashup Score: 1
Summary:. Cell-free tumor DNA has previously been detected in nonblood sources, including urine, saliva, stool, cerebrospinal fluid, and pleural fluid. In this issue, Saura and colleagues present a novel proof-of-concept study demonstrating that detection of tumor DNA in breast milk is feasible and may be a potential future strategy to screen for postpartum breast cancer.See related article by Saura et al., p. 2180 (14).
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In the Spotlight— #Liquidbiopsies in breast milk for the early detection of #breastcancer, by Niamh Cunningham and Nicholas C. Turner. https://t.co/uFijtNcY2V @ICR_London @royalmarsden https://t.co/lrW4FkogHU
-
-
Mashup Score: 1Cell Press Selections 2023_miRNAs at the forefront of disease - 7 month(s) ago
miRNAs at the forefront of disease
Source: info.cell.comCategories: General Medicine News, Latest HeadlinesTweet-
Read the latest research on #ExtravecullarVesicles, #LiquidBiopsies, and #RNASequencing in disease assessment. https://t.co/Do3ruALm95 https://t.co/DPQkgcvm36
-
-
Mashup Score: 2
Detection of circulating tumor DNA (ctDNA)is a minimally invasive and convenient blood-based screening strategy that may increase effectiveness of colorectal cancer (CRC) screening.
Source: www.annalsofoncology.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
👇🏾very cool study @Annals_Oncology. Future of #LiquidBiopsies is multi-omics. This is what the group has done. Why just look at the cancer with one lens when you can do: ✔️Genomics ✔️Epigenomics ✔️Fragmentomics ✔️Proteomics @OncoAlert @isliquidbiopsy https://t.co/PKIwX9LjtZ https://t.co/CQmDiDitqA
-
-
Mashup Score: 1
Results published in Cancer Discovery suggest that a breast milk liquid biopsy could detect breast cancer in pregnant or postpartum people.
Source: www.oncology-central.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Researchers at @VHIO reveal a potential game-changing tool for #BreastCancer screening. Read all about the fascinating origins of this research on Oncology Central. #LiquidBiopsies https://t.co/X61tzPqgYs
-
-
Mashup Score: 1The Promise of Liquid Biopsies | Cancer Today - 7 month(s) ago
Blood tests that detect traces of cancer cells and tumor DNA help find residual disease after treatment is completed.
Source: www.cancertodaymag.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
📚@CancerTodayMag @AACR feature on ongoing debate and questions relevant to the world of #LiquidBiopsies 🧪 🧬. If you get a chance to read our interview. ✍🏽 @tarahaelle These articles are important to help increase awareness and generate discussion. https://t.co/9b8pPbgDgE https://t.co/JI94kC8XLa
-
-
Mashup Score: 0How to Bring Basic Science Discoveries to the Clinic | EACR-AACR-IACR Basic and Translational Research Conference - 9 month(s) ago
The European Association for Cancer Research (EACR) and American Association for Cancer Research (AACR) are proud to continue their Basic and Translational Research Conference series with this new joint conference in Dublin, Ireland in collaboration with the Irish Association for Cancer Research (IACR). Gathering top experts in the fields of immunology, drug development, tumour microenvironment, genomics and epigenetics, this Joint Conference will focus on bringing the latest discoveries from basic
Source: www.eai2024.orgCategories: Latest Headlines, Oncologists1Tweet-
https://t.co/zHRjWNOC9b 🔬Fantastic line up of international speakers. 💊 Topics: Immuno-Oncology, Cell Based Therapies, Novel Targets, Drug Combinations, Drug Resistance, Precancer Genome, #LiquidBiopsies, Preclinical Models, Tumor Microenvironment, Epigenetics. @AACR @EACRnews https://t.co/kgtaOOSiuQ https://t.co/lw1yyGDSRC
-
Join us in Dublin, Ireland Feb. 27-29, 2024 for this exciting joint international conference: "How to Bring Basic Science Discoveries to the Clinic" co-sponsored by @AACR @EACRnews + Irish Association for Cancer Research. 🧵/1 https://t.co/zHRjWNOC9b https://t.co/aU5MpBAbmQ
-
-
Mashup Score: 2Cell Press Selections 2023_miRNAs at the forefront of disease - 9 month(s) ago
miRNAs at the forefront of disease
Source: info.cell.comCategories: General Medicine News, Latest HeadlinesTweet-
A collection of articles using #ExtravecullarVesicles, #LiquidBiopsies, and #RNASequencing in disease assessment. https://t.co/lnL4YtZp1F https://t.co/pzRqsrLcdL
-
-
Mashup Score: 0CCF Webinar: How "liquid biopsies" are helping with precision medicine for patients with cancer - 10 month(s) ago
Advances are coming in subsets for patients with cancers. Newer drugs are like lock and key; the lock has to be present for the key to work. In this webinar,…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
👇🏾See my webinar on🩸#LiquidBiopsies hosted by Cholangiocarcinoma Foundation @curecc, and how it’s helping with Precision Medicine. Also on Facebook Live. ctDNA is not meant to replace tissue. It’s complimentary. 💡Ideally both or plasma-1st. 📺 https://t.co/ebJYktpC5C
-
📚@CancerTodayMag @AACR feature on ongoing debate and questions relevant to the world of #LiquidBiopsies 🧪 🧬. If you get a chance to read our interview. ✍🏽 @tarahaelle These articles are important to help increase awareness and generate discussion. https://t.co/9b8pPbgDgE https://t.co/JI94kC8XLa